Literature DB >> 30355150

Cellular and Molecular Mechanisms of Prion Disease.

Christina J Sigurdson1, Jason C Bartz2, Markus Glatzel3.   

Abstract

Prion diseases are rapidly progressive, incurable neurodegenerative disorders caused by misfolded, aggregated proteins known as prions, which are uniquely infectious. Remarkably, these infectious proteins have been responsible for widespread disease epidemics, including kuru in humans, bovine spongiform encephalopathy in cattle, and chronic wasting disease in cervids, the latter of which has spread across North America and recently appeared in Norway and Finland. The hallmark histopathological features include widespread spongiform encephalopathy, neuronal loss, gliosis, and deposits of variably sized aggregated prion protein, ranging from small, soluble oligomers to long, thin, unbranched fibrils, depending on the disease. Here, we explore recent advances in prion disease research, from the function of the cellular prion protein to the dysfunction triggering neurotoxicity, as well as mechanisms underlying prion spread between cells. We also highlight key findings that have revealed new therapeutic targets and consider unanswered questions for future research.

Entities:  

Keywords:  amyloid; neurodegeneration; neurotoxicity; prion transmission; strains

Mesh:

Substances:

Year:  2018        PMID: 30355150      PMCID: PMC9071098          DOI: 10.1146/annurev-pathmechdis-012418-013109

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   32.350


  198 in total

Review 1.  Pathoanatomy of Parkinson's disease.

Authors:  H Braak; E Braak
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.

Authors:  Mark D Zabel; Mathias Heikenwalder; Marco Prinz; Isabelle Arrighi; Petra Schwarz; Jan Kranich; Adriana von Teichman; Karen M Haas; Nicolas Zeller; Thomas F Tedder; John H Weis; Adriano Aguzzi
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

3.  Unaltered prion protein cleavage in plasminogen-deficient mice.

Authors:  Kathrin Barnewitz; Marko Maringer; Gerda Mitteregger; Armin Giese; Uwe Bertsch; Hans A Kretzschmar
Journal:  Neuroreport       Date:  2006-04-03       Impact factor: 1.837

4.  The same prion strain causes vCJD and BSE.

Authors:  A F Hill; M Desbruslais; S Joiner; K C Sidle; I Gowland; J Collinge; L J Doey; P Lantos
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

Review 5.  Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.

Authors:  Claudio Hetz; Bertrand Mollereau
Journal:  Nat Rev Neurosci       Date:  2014-03-12       Impact factor: 34.870

6.  Strain characterization of the Korean CWD cases in 2001 and 2004.

Authors:  Yoon-Hee Lee; Hyun-Joo Sohn; Min-Jeong Kim; Hyo-Jin Kim; Won-Yong Lee; Eun-Im Yun; Dong-Seob Tark; In-Soo Cho; Aru Balachandran
Journal:  J Vet Med Sci       Date:  2012-08-28       Impact factor: 1.267

7.  Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent.

Authors:  Ragna Heggebø; Charles McL Press; Gjermund Gunnes; Kai Inge Lie; Michael A Tranulis; Martha Ulvund; Martin H Groschup; Thor Landsverk
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

8.  Separate mechanisms act concurrently to shed and release the prion protein from the cell.

Authors:  Lotta Wik; Mikael Klingeborn; Hanna Willander; Tommy Linne
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

9.  Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle.

Authors:  Kentaro Masujin; Danny Matthews; Gerald A H Wells; Shirou Mohri; Takashi Yokoyama
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

Review 10.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

View more
  20 in total

1.  β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Alexander E Kritikos; Ewald Lindner; Neena Singh
Journal:  Exp Eye Res       Date:  2021-10-07       Impact factor: 3.467

Review 2.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

Review 3.  Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.

Authors:  Maria Elena Cicardi; Lara Marrone; Mimoun Azzouz; Davide Trotti
Journal:  EMBO J       Date:  2021-03-31       Impact factor: 11.598

4.  Large-scale lipidomic profiling identifies novel potential biomarkers for prion diseases and highlights lipid raft-related pathways.

Authors:  Yong-Chan Kim; Junbeom Lee; Dae-Weon Lee; Byung-Hoon Jeong
Journal:  Vet Res       Date:  2021-07-21       Impact factor: 3.683

Review 5.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

6.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

7.  New Drosophila models to uncover the intrinsic and extrinsic factors that mediate the toxicity of the human prion protein.

Authors:  Ryan R Myers; Jonatan Sanchez-Garcia; Daniel C Leving; Richard G Melvin; Pedro Fernandez-Funez
Journal:  Dis Model Mech       Date:  2022-05-03       Impact factor: 5.732

8.  Cellular prion protein gene polymorphisms linked to differential scrapie susceptibility correlate with distinct residue connectivity between secondary structure elements.

Authors:  Patricia Soto; India A Claflin; Alyssa L Bursott; Aimee D Schwab-McCoy; Jason C Bartz
Journal:  J Biomol Struct Dyn       Date:  2020-01-08

9.  Upregulation of brain hepcidin in prion diseases.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Dallas McDonald; Alexander E Kritikos; Qingzhong Kong; Neena Singh
Journal:  Prion       Date:  2021-12       Impact factor: 2.547

10.  Medial Temporal Lobe Involvement in Human Prion Diseases: Implications for the Study of Focal Non Prion Neurodegenerative Pathology.

Authors:  Alberto Rábano; Carmen Guerrero Márquez; Ramón A Juste; María V Geijo; Miguel Calero
Journal:  Biomolecules       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.